COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine
• Epidemiological studies conclude diabetes to be a leading comorbidity of COVID-19. • ACE2 polymorphisms in host can influence SARS-CoV-2 susceptibility or resistance. • The in-silico data need to be corroborated with in-vivo results. • Telemedicine can bring a new change in diabetes care.
| Veröffentlicht in: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.] |
|---|---|
| 1. Verfasser: | |
| Format: | Online-Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2021
|
| Zugriff auf das übergeordnete Werk: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients |
| Schlagworte: | hDPP4 CORONADO T1D SARS-CoV TEDDY DM MERS-CoV CFR COVID-19 DPP4 mehr... |
| Umfang: | 6 |
| Online verfügbar |
Volltext |